nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Pregnancy—Lovastatin—atherosclerosis	0.0143	0.0211	CcSEcCtD
Glycopyrrolate—Pregnancy—Simvastatin—atherosclerosis	0.0133	0.0197	CcSEcCtD
Glycopyrrolate—Upset stomach—Lovastatin—atherosclerosis	0.0123	0.0182	CcSEcCtD
Glycopyrrolate—Upset stomach—Simvastatin—atherosclerosis	0.0116	0.0171	CcSEcCtD
Glycopyrrolate—Gastroenteritis—Rosuvastatin—atherosclerosis	0.00782	0.0116	CcSEcCtD
Glycopyrrolate—Pain in extremity—Lovastatin—atherosclerosis	0.00587	0.00868	CcSEcCtD
Glycopyrrolate—Atrial fibrillation—Simvastatin—atherosclerosis	0.0058	0.00857	CcSEcCtD
Glycopyrrolate—Pain in extremity—Ezetimibe—atherosclerosis	0.00576	0.00851	CcSEcCtD
Glycopyrrolate—Atrial fibrillation—Niacin—atherosclerosis	0.00532	0.00786	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00519	0.00767	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00515	0.00761	CcSEcCtD
Glycopyrrolate—Sinusitis—Rosuvastatin—atherosclerosis	0.00501	0.0074	CcSEcCtD
Glycopyrrolate—Affect lability—Pravastatin—atherosclerosis	0.00489	0.00722	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Lovastatin—atherosclerosis	0.00487	0.00719	CcSEcCtD
Glycopyrrolate—Rhinitis—Rosuvastatin—atherosclerosis	0.00481	0.0071	CcSEcCtD
Glycopyrrolate—Urinary retention—Niacin—atherosclerosis	0.0048	0.00709	CcSEcCtD
Glycopyrrolate—Mood swings—Pravastatin—atherosclerosis	0.00471	0.00695	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Lovastatin—atherosclerosis	0.00468	0.00691	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00463	0.00684	CcSEcCtD
Glycopyrrolate—Dry skin—Niacin—atherosclerosis	0.00462	0.00683	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00459	0.00678	CcSEcCtD
Glycopyrrolate—Dry skin—Pravastatin—atherosclerosis	0.00455	0.00673	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Simvastatin—atherosclerosis	0.00455	0.00673	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Pravastatin—atherosclerosis	0.00444	0.00656	CcSEcCtD
Glycopyrrolate—Infestation NOS—Ezetimibe—atherosclerosis	0.00444	0.00656	CcSEcCtD
Glycopyrrolate—Infestation—Ezetimibe—atherosclerosis	0.00444	0.00656	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00441	0.00652	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Lovastatin—atherosclerosis	0.0044	0.0065	CcSEcCtD
Glycopyrrolate—Abdominal distension—Niacin—atherosclerosis	0.00439	0.00648	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Simvastatin—atherosclerosis	0.00437	0.00646	CcSEcCtD
Glycopyrrolate—Abdominal distension—Pravastatin—atherosclerosis	0.00432	0.00638	CcSEcCtD
Glycopyrrolate—Sinusitis—Lovastatin—atherosclerosis	0.00425	0.00627	CcSEcCtD
Glycopyrrolate—Mental disorder—Rosuvastatin—atherosclerosis	0.0042	0.00621	CcSEcCtD
Glycopyrrolate—Sinusitis—Ezetimibe—atherosclerosis	0.00416	0.00615	CcSEcCtD
Glycopyrrolate—Flatulence—Rosuvastatin—atherosclerosis	0.00411	0.00608	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Niacin—atherosclerosis	0.00402	0.00593	CcSEcCtD
Glycopyrrolate—Dysuria—Pravastatin—atherosclerosis	0.00401	0.00593	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00399	0.00589	CcSEcCtD
Glycopyrrolate—Sinusitis—Simvastatin—atherosclerosis	0.00397	0.00587	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Pravastatin—atherosclerosis	0.00395	0.00584	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00392	0.00579	CcSEcCtD
Glycopyrrolate—Flushing—Lovastatin—atherosclerosis	0.00377	0.00557	CcSEcCtD
Glycopyrrolate—Sweating—Niacin—atherosclerosis	0.00373	0.00551	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Pravastatin—atherosclerosis	0.00372	0.0055	CcSEcCtD
Glycopyrrolate—Flushing—Ezetimibe—atherosclerosis	0.0037	0.00546	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00359	0.00531	CcSEcCtD
Glycopyrrolate—Sinusitis—Pravastatin—atherosclerosis	0.00359	0.00531	CcSEcCtD
Glycopyrrolate—Flushing—Simvastatin—atherosclerosis	0.00353	0.00521	CcSEcCtD
Glycopyrrolate—Rhinitis—Niacin—atherosclerosis	0.0035	0.00517	CcSEcCtD
Glycopyrrolate—Mental disorder—Ezetimibe—atherosclerosis	0.00349	0.00516	CcSEcCtD
Glycopyrrolate—Flatulence—Lovastatin—atherosclerosis	0.00349	0.00515	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Niacin—atherosclerosis	0.00347	0.00513	CcSEcCtD
Glycopyrrolate—Malnutrition—Ezetimibe—atherosclerosis	0.00347	0.00513	CcSEcCtD
Glycopyrrolate—Erythema—Ezetimibe—atherosclerosis	0.00347	0.00513	CcSEcCtD
Glycopyrrolate—Dysgeusia—Lovastatin—atherosclerosis	0.00346	0.00512	CcSEcCtD
Glycopyrrolate—Rhinitis—Pravastatin—atherosclerosis	0.00344	0.00509	CcSEcCtD
Glycopyrrolate—Confusional state—Rosuvastatin—atherosclerosis	0.00343	0.00507	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Pravastatin—atherosclerosis	0.00342	0.00505	CcSEcCtD
Glycopyrrolate—Flatulence—Ezetimibe—atherosclerosis	0.00342	0.00505	CcSEcCtD
Glycopyrrolate—Infection—Rosuvastatin—atherosclerosis	0.00338	0.005	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00334	0.00494	CcSEcCtD
Glycopyrrolate—Vision blurred—Lovastatin—atherosclerosis	0.00333	0.00493	CcSEcCtD
Glycopyrrolate—Mental disorder—Simvastatin—atherosclerosis	0.00333	0.00492	CcSEcCtD
Glycopyrrolate—Erythema—Simvastatin—atherosclerosis	0.00331	0.00489	CcSEcCtD
Glycopyrrolate—Flatulence—Simvastatin—atherosclerosis	0.00326	0.00482	CcSEcCtD
Glycopyrrolate—Dysgeusia—Simvastatin—atherosclerosis	0.00324	0.00479	CcSEcCtD
Glycopyrrolate—Flushing—Niacin—atherosclerosis	0.00324	0.00479	CcSEcCtD
Glycopyrrolate—Flushing—Pravastatin—atherosclerosis	0.00319	0.00471	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Pravastatin—atherosclerosis	0.00319	0.00471	CcSEcCtD
Glycopyrrolate—Vision blurred—Simvastatin—atherosclerosis	0.00312	0.00461	CcSEcCtD
Glycopyrrolate—Insomnia—Rosuvastatin—atherosclerosis	0.00308	0.00455	CcSEcCtD
Glycopyrrolate—Palpitations—Ezetimibe—atherosclerosis	0.00307	0.00453	CcSEcCtD
Glycopyrrolate—Malnutrition—Niacin—atherosclerosis	0.00304	0.00449	CcSEcCtD
Glycopyrrolate—Erythema—Niacin—atherosclerosis	0.00304	0.00449	CcSEcCtD
Glycopyrrolate—Dyspepsia—Rosuvastatin—atherosclerosis	0.003	0.00443	CcSEcCtD
Glycopyrrolate—Hypertension—Ezetimibe—atherosclerosis	0.003	0.00443	CcSEcCtD
Glycopyrrolate—Flatulence—Niacin—atherosclerosis	0.00299	0.00442	CcSEcCtD
Glycopyrrolate—Tension—Niacin—atherosclerosis	0.00298	0.0044	CcSEcCtD
Glycopyrrolate—Nervousness—Niacin—atherosclerosis	0.00295	0.00436	CcSEcCtD
Glycopyrrolate—Flatulence—Pravastatin—atherosclerosis	0.00295	0.00435	CcSEcCtD
Glycopyrrolate—Dry mouth—Lovastatin—atherosclerosis	0.00295	0.00435	CcSEcCtD
Glycopyrrolate—Tension—Pravastatin—atherosclerosis	0.00294	0.00434	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00293	0.00433	CcSEcCtD
Glycopyrrolate—Dysgeusia—Pravastatin—atherosclerosis	0.00293	0.00433	CcSEcCtD
Glycopyrrolate—Constipation—Rosuvastatin—atherosclerosis	0.00291	0.0043	CcSEcCtD
Glycopyrrolate—Pain—Rosuvastatin—atherosclerosis	0.00291	0.0043	CcSEcCtD
Glycopyrrolate—Confusional state—Lovastatin—atherosclerosis	0.00291	0.0043	CcSEcCtD
Glycopyrrolate—Nervousness—Pravastatin—atherosclerosis	0.00291	0.00429	CcSEcCtD
Glycopyrrolate—Dry mouth—Ezetimibe—atherosclerosis	0.00289	0.00427	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Lovastatin—atherosclerosis	0.00289	0.00427	CcSEcCtD
Glycopyrrolate—Infection—Lovastatin—atherosclerosis	0.00287	0.00424	CcSEcCtD
Glycopyrrolate—Vision blurred—Niacin—atherosclerosis	0.00286	0.00423	CcSEcCtD
Glycopyrrolate—Confusional state—Ezetimibe—atherosclerosis	0.00285	0.00422	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00283	0.00418	CcSEcCtD
Glycopyrrolate—Vision blurred—Pravastatin—atherosclerosis	0.00282	0.00416	CcSEcCtD
Glycopyrrolate—Infection—Ezetimibe—atherosclerosis	0.00281	0.00416	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00281	0.00415	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00279	0.00412	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Ezetimibe—atherosclerosis	0.00278	0.0041	CcSEcCtD
Glycopyrrolate—Skin disorder—Ezetimibe—atherosclerosis	0.00275	0.00406	CcSEcCtD
Glycopyrrolate—Confusional state—Simvastatin—atherosclerosis	0.00272	0.00402	CcSEcCtD
Glycopyrrolate—Urticaria—Rosuvastatin—atherosclerosis	0.00271	0.004	CcSEcCtD
Glycopyrrolate—Oedema—Simvastatin—atherosclerosis	0.0027	0.00399	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Simvastatin—atherosclerosis	0.0027	0.00399	CcSEcCtD
Glycopyrrolate—Abdominal pain—Rosuvastatin—atherosclerosis	0.00269	0.00398	CcSEcCtD
Glycopyrrolate—Palpitations—Niacin—atherosclerosis	0.00268	0.00397	CcSEcCtD
Glycopyrrolate—Infection—Simvastatin—atherosclerosis	0.00268	0.00396	CcSEcCtD
Glycopyrrolate—Insomnia—Lovastatin—atherosclerosis	0.00261	0.00386	CcSEcCtD
Glycopyrrolate—Hypertension—Pravastatin—atherosclerosis	0.00258	0.00382	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00257	0.00379	CcSEcCtD
Glycopyrrolate—Insomnia—Ezetimibe—atherosclerosis	0.00256	0.00378	CcSEcCtD
Glycopyrrolate—Dyspepsia—Lovastatin—atherosclerosis	0.00254	0.00375	CcSEcCtD
Glycopyrrolate—Dry mouth—Niacin—atherosclerosis	0.00253	0.00374	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00251	0.00371	CcSEcCtD
Glycopyrrolate—Dyspepsia—Ezetimibe—atherosclerosis	0.00249	0.00368	CcSEcCtD
Glycopyrrolate—Fatigue—Lovastatin—atherosclerosis	0.00249	0.00368	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Niacin—atherosclerosis	0.00248	0.00366	CcSEcCtD
Glycopyrrolate—Oedema—Niacin—atherosclerosis	0.00248	0.00366	CcSEcCtD
Glycopyrrolate—Pain—Lovastatin—atherosclerosis	0.00247	0.00365	CcSEcCtD
Glycopyrrolate—Constipation—Lovastatin—atherosclerosis	0.00247	0.00365	CcSEcCtD
Glycopyrrolate—Confusional state—Pravastatin—atherosclerosis	0.00246	0.00364	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00244	0.00361	CcSEcCtD
Glycopyrrolate—Asthenia—Rosuvastatin—atherosclerosis	0.00244	0.00361	CcSEcCtD
Glycopyrrolate—Insomnia—Simvastatin—atherosclerosis	0.00244	0.00361	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Pravastatin—atherosclerosis	0.00244	0.00361	CcSEcCtD
Glycopyrrolate—Oedema—Pravastatin—atherosclerosis	0.00244	0.00361	CcSEcCtD
Glycopyrrolate—Fatigue—Ezetimibe—atherosclerosis	0.00244	0.00361	CcSEcCtD
Glycopyrrolate—Infection—Pravastatin—atherosclerosis	0.00243	0.00358	CcSEcCtD
Glycopyrrolate—Pain—Ezetimibe—atherosclerosis	0.00242	0.00358	CcSEcCtD
Glycopyrrolate—Constipation—Ezetimibe—atherosclerosis	0.00242	0.00358	CcSEcCtD
Glycopyrrolate—Tachycardia—Niacin—atherosclerosis	0.00242	0.00358	CcSEcCtD
Glycopyrrolate—Pruritus—Rosuvastatin—atherosclerosis	0.00241	0.00356	CcSEcCtD
Glycopyrrolate—Skin disorder—Niacin—atherosclerosis	0.00241	0.00356	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Niacin—atherosclerosis	0.0024	0.00354	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Lovastatin—atherosclerosis	0.00238	0.00351	CcSEcCtD
Glycopyrrolate—Dyspepsia—Simvastatin—atherosclerosis	0.00238	0.00351	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00236	0.00349	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Pravastatin—atherosclerosis	0.00236	0.00349	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Ezetimibe—atherosclerosis	0.00233	0.00345	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00233	0.00344	CcSEcCtD
Glycopyrrolate—Fatigue—Simvastatin—atherosclerosis	0.00233	0.00344	CcSEcCtD
Glycopyrrolate—Hypotension—Niacin—atherosclerosis	0.00232	0.00342	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00232	0.00342	CcSEcCtD
Glycopyrrolate—Constipation—Simvastatin—atherosclerosis	0.00231	0.00341	CcSEcCtD
Glycopyrrolate—Pain—Simvastatin—atherosclerosis	0.00231	0.00341	CcSEcCtD
Glycopyrrolate—Urticaria—Lovastatin—atherosclerosis	0.00229	0.00339	CcSEcCtD
Glycopyrrolate—Body temperature increased—Lovastatin—atherosclerosis	0.00228	0.00337	CcSEcCtD
Glycopyrrolate—Abdominal pain—Lovastatin—atherosclerosis	0.00228	0.00337	CcSEcCtD
Glycopyrrolate—Dizziness—Rosuvastatin—atherosclerosis	0.00225	0.00333	CcSEcCtD
Glycopyrrolate—Urticaria—Ezetimibe—atherosclerosis	0.00225	0.00332	CcSEcCtD
Glycopyrrolate—Insomnia—Niacin—atherosclerosis	0.00224	0.00331	CcSEcCtD
Glycopyrrolate—Abdominal pain—Ezetimibe—atherosclerosis	0.00224	0.00331	CcSEcCtD
Glycopyrrolate—Body temperature increased—Ezetimibe—atherosclerosis	0.00224	0.00331	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Simvastatin—atherosclerosis	0.00223	0.00329	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00221	0.00326	CcSEcCtD
Glycopyrrolate—Insomnia—Pravastatin—atherosclerosis	0.00221	0.00326	CcSEcCtD
Glycopyrrolate—Somnolence—Niacin—atherosclerosis	0.0022	0.00326	CcSEcCtD
Glycopyrrolate—Dyspepsia—Niacin—atherosclerosis	0.00218	0.00322	CcSEcCtD
Glycopyrrolate—Dyspepsia—Pravastatin—atherosclerosis	0.00215	0.00317	CcSEcCtD
Glycopyrrolate—Rash—Rosuvastatin—atherosclerosis	0.00215	0.00317	CcSEcCtD
Glycopyrrolate—Dermatitis—Rosuvastatin—atherosclerosis	0.00215	0.00317	CcSEcCtD
Glycopyrrolate—Urticaria—Simvastatin—atherosclerosis	0.00215	0.00317	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Niacin—atherosclerosis	0.00214	0.00316	CcSEcCtD
Glycopyrrolate—Abdominal pain—Simvastatin—atherosclerosis	0.00213	0.00315	CcSEcCtD
Glycopyrrolate—Body temperature increased—Simvastatin—atherosclerosis	0.00213	0.00315	CcSEcCtD
Glycopyrrolate—Headache—Rosuvastatin—atherosclerosis	0.00213	0.00315	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Lovastatin—atherosclerosis	0.00213	0.00314	CcSEcCtD
Glycopyrrolate—Pain—Niacin—atherosclerosis	0.00212	0.00313	CcSEcCtD
Glycopyrrolate—Fatigue—Pravastatin—atherosclerosis	0.0021	0.00311	CcSEcCtD
Glycopyrrolate—Pain—Pravastatin—atherosclerosis	0.00209	0.00308	CcSEcCtD
Glycopyrrolate—Constipation—Pravastatin—atherosclerosis	0.00209	0.00308	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Ezetimibe—atherosclerosis	0.00209	0.00308	CcSEcCtD
Glycopyrrolate—Asthenia—Lovastatin—atherosclerosis	0.00207	0.00306	CcSEcCtD
Glycopyrrolate—Pruritus—Lovastatin—atherosclerosis	0.00204	0.00302	CcSEcCtD
Glycopyrrolate—Asthenia—Ezetimibe—atherosclerosis	0.00203	0.003	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Niacin—atherosclerosis	0.00203	0.003	CcSEcCtD
Glycopyrrolate—Nausea—Rosuvastatin—atherosclerosis	0.00202	0.00299	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Pravastatin—atherosclerosis	0.00201	0.00297	CcSEcCtD
Glycopyrrolate—Pruritus—Ezetimibe—atherosclerosis	0.002	0.00296	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.002	0.00295	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Simvastatin—atherosclerosis	0.00199	0.00294	CcSEcCtD
Glycopyrrolate—Urticaria—Niacin—atherosclerosis	0.00197	0.00291	CcSEcCtD
Glycopyrrolate—Body temperature increased—Niacin—atherosclerosis	0.00196	0.0029	CcSEcCtD
Glycopyrrolate—Abdominal pain—Niacin—atherosclerosis	0.00196	0.0029	CcSEcCtD
Glycopyrrolate—Urticaria—Pravastatin—atherosclerosis	0.00194	0.00287	CcSEcCtD
Glycopyrrolate—Asthenia—Simvastatin—atherosclerosis	0.00194	0.00286	CcSEcCtD
Glycopyrrolate—Body temperature increased—Pravastatin—atherosclerosis	0.00193	0.00285	CcSEcCtD
Glycopyrrolate—Abdominal pain—Pravastatin—atherosclerosis	0.00193	0.00285	CcSEcCtD
Glycopyrrolate—Pruritus—Simvastatin—atherosclerosis	0.00191	0.00282	CcSEcCtD
Glycopyrrolate—Dizziness—Lovastatin—atherosclerosis	0.00191	0.00282	CcSEcCtD
Glycopyrrolate—Dizziness—Ezetimibe—atherosclerosis	0.00187	0.00277	CcSEcCtD
Glycopyrrolate—Vomiting—Lovastatin—atherosclerosis	0.00184	0.00271	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Niacin—atherosclerosis	0.00183	0.0027	CcSEcCtD
Glycopyrrolate—Rash—Lovastatin—atherosclerosis	0.00182	0.00269	CcSEcCtD
Glycopyrrolate—Dermatitis—Lovastatin—atherosclerosis	0.00182	0.00269	CcSEcCtD
Glycopyrrolate—Headache—Lovastatin—atherosclerosis	0.00181	0.00267	CcSEcCtD
Glycopyrrolate—Vomiting—Ezetimibe—atherosclerosis	0.0018	0.00266	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Pravastatin—atherosclerosis	0.0018	0.00266	CcSEcCtD
Glycopyrrolate—Dizziness—Simvastatin—atherosclerosis	0.00179	0.00264	CcSEcCtD
Glycopyrrolate—Rash—Ezetimibe—atherosclerosis	0.00179	0.00264	CcSEcCtD
Glycopyrrolate—Dermatitis—Ezetimibe—atherosclerosis	0.00178	0.00264	CcSEcCtD
Glycopyrrolate—Asthenia—Niacin—atherosclerosis	0.00178	0.00263	CcSEcCtD
Glycopyrrolate—Headache—Ezetimibe—atherosclerosis	0.00177	0.00262	CcSEcCtD
Glycopyrrolate—Pruritus—Niacin—atherosclerosis	0.00175	0.00259	CcSEcCtD
Glycopyrrolate—Asthenia—Pravastatin—atherosclerosis	0.00175	0.00259	CcSEcCtD
Glycopyrrolate—Pruritus—Pravastatin—atherosclerosis	0.00173	0.00255	CcSEcCtD
Glycopyrrolate—Vomiting—Simvastatin—atherosclerosis	0.00172	0.00254	CcSEcCtD
Glycopyrrolate—Nausea—Lovastatin—atherosclerosis	0.00171	0.00253	CcSEcCtD
Glycopyrrolate—Rash—Simvastatin—atherosclerosis	0.0017	0.00252	CcSEcCtD
Glycopyrrolate—Dermatitis—Simvastatin—atherosclerosis	0.0017	0.00251	CcSEcCtD
Glycopyrrolate—Headache—Simvastatin—atherosclerosis	0.00169	0.0025	CcSEcCtD
Glycopyrrolate—Nausea—Ezetimibe—atherosclerosis	0.00168	0.00248	CcSEcCtD
Glycopyrrolate—Dizziness—Niacin—atherosclerosis	0.00164	0.00242	CcSEcCtD
Glycopyrrolate—Dizziness—Pravastatin—atherosclerosis	0.00161	0.00239	CcSEcCtD
Glycopyrrolate—Nausea—Simvastatin—atherosclerosis	0.0016	0.00237	CcSEcCtD
Glycopyrrolate—Vomiting—Niacin—atherosclerosis	0.00158	0.00233	CcSEcCtD
Glycopyrrolate—Rash—Niacin—atherosclerosis	0.00156	0.00231	CcSEcCtD
Glycopyrrolate—Dermatitis—Niacin—atherosclerosis	0.00156	0.00231	CcSEcCtD
Glycopyrrolate—Headache—Niacin—atherosclerosis	0.00155	0.00229	CcSEcCtD
Glycopyrrolate—Vomiting—Pravastatin—atherosclerosis	0.00155	0.00229	CcSEcCtD
Glycopyrrolate—Rash—Pravastatin—atherosclerosis	0.00154	0.00227	CcSEcCtD
Glycopyrrolate—Dermatitis—Pravastatin—atherosclerosis	0.00154	0.00227	CcSEcCtD
Glycopyrrolate—Headache—Pravastatin—atherosclerosis	0.00153	0.00226	CcSEcCtD
Glycopyrrolate—Nausea—Niacin—atherosclerosis	0.00147	0.00218	CcSEcCtD
Glycopyrrolate—Nausea—Pravastatin—atherosclerosis	0.00145	0.00214	CcSEcCtD
Glycopyrrolate—CHRM2—Signaling Pathways—NCF1—atherosclerosis	9.89e-05	0.000306	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APOB—atherosclerosis	9.85e-05	0.000305	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—LPL—atherosclerosis	9.82e-05	0.000304	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CXCL8—atherosclerosis	9.76e-05	0.000302	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—F2—atherosclerosis	9.75e-05	0.000302	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—F2—atherosclerosis	9.72e-05	0.000301	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EDN1—atherosclerosis	9.69e-05	0.0003	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—F2—atherosclerosis	9.63e-05	0.000298	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL5—atherosclerosis	9.61e-05	0.000298	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AGT—atherosclerosis	9.59e-05	0.000297	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AGT—atherosclerosis	9.56e-05	0.000296	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PRKCG—atherosclerosis	9.54e-05	0.000295	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR2—atherosclerosis	9.46e-05	0.000293	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	9.46e-05	0.000293	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AGT—atherosclerosis	9.46e-05	0.000293	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	9.43e-05	0.000292	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR2—atherosclerosis	9.43e-05	0.000292	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CYBA—atherosclerosis	9.42e-05	0.000292	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—LPL—atherosclerosis	9.4e-05	0.000291	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CYBA—atherosclerosis	9.39e-05	0.000291	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	9.34e-05	0.000289	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR2—atherosclerosis	9.34e-05	0.000289	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	9.33e-05	0.000289	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	9.3e-05	0.000288	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CYBA—atherosclerosis	9.3e-05	0.000288	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SPP1—atherosclerosis	9.3e-05	0.000288	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCL8—atherosclerosis	9.26e-05	0.000286	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—GHRL—atherosclerosis	9.22e-05	0.000285	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PLAT—atherosclerosis	9.22e-05	0.000285	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PARP1—atherosclerosis	9.22e-05	0.000285	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	9.21e-05	0.000285	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PLAT—atherosclerosis	9.19e-05	0.000284	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—GHRL—atherosclerosis	9.19e-05	0.000284	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PARP1—atherosclerosis	9.19e-05	0.000284	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PRKCG—atherosclerosis	9.14e-05	0.000283	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PLAT—atherosclerosis	9.1e-05	0.000282	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—GHRL—atherosclerosis	9.1e-05	0.000282	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PARP1—atherosclerosis	9.1e-05	0.000282	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SPP1—atherosclerosis	8.9e-05	0.000276	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCL8—atherosclerosis	8.86e-05	0.000274	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—F2—atherosclerosis	8.86e-05	0.000274	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—F2—atherosclerosis	8.83e-05	0.000273	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—F2—atherosclerosis	8.74e-05	0.000271	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—HMOX1—atherosclerosis	8.63e-05	0.000267	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PDGFB—atherosclerosis	8.6e-05	0.000266	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	8.48e-05	0.000262	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	8.45e-05	0.000261	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AGT—atherosclerosis	8.4e-05	0.00026	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	8.37e-05	0.000259	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOB—atherosclerosis	8.26e-05	0.000256	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PDGFB—atherosclerosis	8.24e-05	0.000255	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—LEP—atherosclerosis	8.23e-05	0.000255	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—APOE—atherosclerosis	8.23e-05	0.000255	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CAV1—atherosclerosis	8.15e-05	0.000252	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—APOA1—atherosclerosis	8.13e-05	0.000252	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KNG1—atherosclerosis	8.1e-05	0.000251	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KNG1—atherosclerosis	8.07e-05	0.00025	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	8.05e-05	0.000249	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AGT—atherosclerosis	8.04e-05	0.000249	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GSTM1—atherosclerosis	8.04e-05	0.000249	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	8.02e-05	0.000248	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KNG1—atherosclerosis	7.99e-05	0.000247	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	7.94e-05	0.000246	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	7.89e-05	0.000244	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—LPL—atherosclerosis	7.89e-05	0.000244	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—LEP—atherosclerosis	7.88e-05	0.000244	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APOE—atherosclerosis	7.88e-05	0.000244	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	7.87e-05	0.000244	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ESR1—atherosclerosis	7.86e-05	0.000243	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PLG—atherosclerosis	7.84e-05	0.000243	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PLG—atherosclerosis	7.82e-05	0.000242	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CAV1—atherosclerosis	7.81e-05	0.000242	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	7.79e-05	0.000241	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APOA1—atherosclerosis	7.79e-05	0.000241	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—F2—atherosclerosis	7.76e-05	0.00024	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PLG—atherosclerosis	7.74e-05	0.00024	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GPX1—atherosclerosis	7.7e-05	0.000238	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ESR1—atherosclerosis	7.52e-05	0.000233	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CD36—atherosclerosis	7.5e-05	0.000232	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—F2—atherosclerosis	7.43e-05	0.00023	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	7.43e-05	0.00023	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CG—atherosclerosis	7.43e-05	0.00023	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	7.4e-05	0.000229	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	7.33e-05	0.000227	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP3—atherosclerosis	7.17e-05	0.000222	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP3—atherosclerosis	7.15e-05	0.000221	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IGF2—atherosclerosis	7.14e-05	0.000221	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IGF2—atherosclerosis	7.12e-05	0.00022	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—MAPK3—atherosclerosis	7.11e-05	0.00022	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CG—atherosclerosis	7.11e-05	0.00022	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—MTHFR—atherosclerosis	7.1e-05	0.00022	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP3—atherosclerosis	7.08e-05	0.000219	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IGF2—atherosclerosis	7.05e-05	0.000218	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—INS—atherosclerosis	7.03e-05	0.000218	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPARA—atherosclerosis	6.97e-05	0.000216	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOB—atherosclerosis	6.93e-05	0.000215	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL2—atherosclerosis	6.92e-05	0.000214	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOB—atherosclerosis	6.91e-05	0.000214	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	6.87e-05	0.000213	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	6.85e-05	0.000212	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOB—atherosclerosis	6.84e-05	0.000212	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EDN1—atherosclerosis	6.82e-05	0.000211	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—MAPK3—atherosclerosis	6.81e-05	0.000211	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EDN1—atherosclerosis	6.8e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IGF1—atherosclerosis	6.8e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	6.78e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL5—atherosclerosis	6.77e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AGT—atherosclerosis	6.75e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL5—atherosclerosis	6.75e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EDN1—atherosclerosis	6.73e-05	0.000208	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—INS—atherosclerosis	6.73e-05	0.000208	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL5—atherosclerosis	6.68e-05	0.000207	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL2—atherosclerosis	6.62e-05	0.000205	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LPL—atherosclerosis	6.62e-05	0.000205	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOE—atherosclerosis	6.61e-05	0.000205	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LPL—atherosclerosis	6.6e-05	0.000204	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CAV1—atherosclerosis	6.55e-05	0.000203	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOA1—atherosclerosis	6.54e-05	0.000202	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LPL—atherosclerosis	6.53e-05	0.000202	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IGF1—atherosclerosis	6.51e-05	0.000201	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SERPINE1—atherosclerosis	6.46e-05	0.0002	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	6.44e-05	0.000199	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	6.42e-05	0.000199	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	6.35e-05	0.000197	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SPP1—atherosclerosis	6.27e-05	0.000194	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SPP1—atherosclerosis	6.25e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	6.24e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	6.22e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SPP1—atherosclerosis	6.19e-05	0.000192	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SERPINE1—atherosclerosis	6.18e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOS3—atherosclerosis	6.16e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	6.16e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CG—atherosclerosis	5.97e-05	0.000185	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOS3—atherosclerosis	5.9e-05	0.000183	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	5.8e-05	0.00018	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	5.78e-05	0.000179	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPARG—atherosclerosis	5.76e-05	0.000178	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	5.73e-05	0.000177	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AGT—atherosclerosis	5.66e-05	0.000175	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—INS—atherosclerosis	5.65e-05	0.000175	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AGT—atherosclerosis	5.64e-05	0.000175	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AGT—atherosclerosis	5.59e-05	0.000173	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LEP—atherosclerosis	5.55e-05	0.000172	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOE—atherosclerosis	5.55e-05	0.000172	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LEP—atherosclerosis	5.53e-05	0.000171	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOE—atherosclerosis	5.53e-05	0.000171	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CAV1—atherosclerosis	5.5e-05	0.00017	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOA1—atherosclerosis	5.48e-05	0.00017	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CAV1—atherosclerosis	5.48e-05	0.00017	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LEP—atherosclerosis	5.48e-05	0.000169	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOE—atherosclerosis	5.48e-05	0.000169	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL8—atherosclerosis	5.47e-05	0.000169	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOA1—atherosclerosis	5.47e-05	0.000169	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CAV1—atherosclerosis	5.43e-05	0.000168	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOA1—atherosclerosis	5.41e-05	0.000168	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ESR1—atherosclerosis	5.3e-05	0.000164	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—AKT1—atherosclerosis	5.28e-05	0.000163	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ESR1—atherosclerosis	5.28e-05	0.000163	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL8—atherosclerosis	5.24e-05	0.000162	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—F2—atherosclerosis	5.23e-05	0.000162	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ESR1—atherosclerosis	5.23e-05	0.000162	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—F2—atherosclerosis	5.22e-05	0.000161	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—atherosclerosis	5.2e-05	0.000161	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALB—atherosclerosis	5.18e-05	0.00016	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—F2—atherosclerosis	5.17e-05	0.00016	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—AKT1—atherosclerosis	5.06e-05	0.000157	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	5.01e-05	0.000155	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	4.99e-05	0.000154	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—atherosclerosis	4.98e-05	0.000154	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—NOS3—atherosclerosis	4.96e-05	0.000153	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MMP9—atherosclerosis	4.95e-05	0.000153	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	4.94e-05	0.000153	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NFKB1—atherosclerosis	4.89e-05	0.000151	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MAPK8—atherosclerosis	4.81e-05	0.000149	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—AKT1—atherosclerosis	4.8e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	4.8e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	4.78e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—INS—atherosclerosis	4.74e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MMP9—atherosclerosis	4.74e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	4.73e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—INS—atherosclerosis	4.72e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NFKB1—atherosclerosis	4.69e-05	0.000145	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—INS—atherosclerosis	4.68e-05	0.000145	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL2—atherosclerosis	4.66e-05	0.000144	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL2—atherosclerosis	4.65e-05	0.000144	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAPK8—atherosclerosis	4.61e-05	0.000143	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL2—atherosclerosis	4.6e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—AKT1—atherosclerosis	4.59e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IGF1—atherosclerosis	4.58e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IGF1—atherosclerosis	4.57e-05	0.000141	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS2—atherosclerosis	4.53e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IGF1—atherosclerosis	4.53e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—VEGFA—atherosclerosis	4.44e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—STAT3—atherosclerosis	4.4e-05	0.000136	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	4.35e-05	0.000135	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	4.34e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	4.3e-05	0.000133	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	4.25e-05	0.000132	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—STAT3—atherosclerosis	4.21e-05	0.00013	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MAPK3—atherosclerosis	4.2e-05	0.00013	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOS3—atherosclerosis	4.16e-05	0.000129	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOS3—atherosclerosis	4.14e-05	0.000128	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOS3—atherosclerosis	4.1e-05	0.000127	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TGFB1—atherosclerosis	4.08e-05	0.000126	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	4.02e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	3.9e-05	0.000121	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	3.69e-05	0.000114	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	3.68e-05	0.000114	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	3.64e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	3.56e-05	0.00011	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	3.55e-05	0.00011	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	3.52e-05	0.000109	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—atherosclerosis	3.51e-05	0.000108	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—atherosclerosis	3.49e-05	0.000108	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—atherosclerosis	3.46e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP9—atherosclerosis	3.33e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP9—atherosclerosis	3.32e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	3.3e-05	0.000102	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP9—atherosclerosis	3.29e-05	0.000102	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	3.29e-05	0.000102	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	3.26e-05	0.000101	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	3.24e-05	0.0001	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	3.23e-05	0.0001	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	3.23e-05	0.0001	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	3.22e-05	9.98e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	3.2e-05	9.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	3.19e-05	9.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—atherosclerosis	3.07e-05	9.51e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	2.99e-05	9.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	2.99e-05	9.24e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—STAT3—atherosclerosis	2.97e-05	9.18e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	2.96e-05	9.15e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—STAT3—atherosclerosis	2.96e-05	9.15e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—atherosclerosis	2.94e-05	9.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—STAT3—atherosclerosis	2.93e-05	9.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AKT1—atherosclerosis	2.83e-05	8.77e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	2.83e-05	8.77e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	2.82e-05	8.74e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	2.8e-05	8.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	2.75e-05	8.51e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	2.74e-05	8.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKT1—atherosclerosis	2.71e-05	8.4e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	2.71e-05	8.4e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AKT1—atherosclerosis	2.28e-05	7.05e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—atherosclerosis	2.07e-05	6.41e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—atherosclerosis	2.06e-05	6.39e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—atherosclerosis	2.04e-05	6.33e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.91e-05	5.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT1—atherosclerosis	1.9e-05	5.89e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.89e-05	5.84e-05	CbGpPWpGaD
